Header Logo

Connection

JONATHAN LEI to Trastuzumab

Back to Details
This is a "connection" page, showing publications JONATHAN LEI has written about Trastuzumab.
JONATHAN LEI
Connection Strength
0.057
Trastuzumab
  1. Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell Rep Med. 2025 Jun 17; 6(6):102154.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.